Mark Fishman

Insider Reports History

Location
Cambridge, MA
Signature
By: /s/ Christine Bellon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Fishman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 33,662 $563,982 $24.40 04 Jun 2025 Direct

Insider Reports Filed by Mark Fishman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BEAM Beam Therapeutics Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
BEAM Beam Therapeutics Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:42
BEAM Beam Therapeutics Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:51
BEAM Beam Therapeutics Inc. 01 Sep 2022 1 $0 4 Director 02 Sep 2022, 16:05
BEAM Beam Therapeutics Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 08:02